瓦尔酸诱导的双:一个案例报告
1Acute Medicine, Mid and South Essex NHS Foundation Trust, Chelmsford, GBR.
Cureus
|November 13, 2025
概括
酸可以引起严重的血清问题,特别是当剂量改变时. 仔细监测和了解患者的遵守是安全管理这些不良影响的关键.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 酸是一种常见的治疗和情绪障碍.
- 血液学异常是已知的甲的不良影响.
- 患者的坚持可以显著影响药物的有效性和安全性.
研究的目的:
- 报告与甲相关的双细胞减肥病例.
- 要突出药物剂量,毒性和患者坚持药物的相互作用.
- 强调警监测在管理甲治疗中的重要性.
主要方法:
- 一个年轻的男性患者的病例报告,患有状态.
- 在剂量调整后对血液学参数 (血红蛋白,血小板) 的分析.
- 评估血清氨酸水平和患者药物服药程度.
- 在剂量修改后评估控制和血清恢复.
主要成果:
- 患者在增加甲的剂量后出现了双细胞减肥.
- 尽管降低了剂量,但血液学参数最初恶化,需要输血.
- 家庭坚持不良导致在住院期间相对过度暴露.
- 降低维护剂量稳定了血清水平,改善了血液细胞计数,控制了发作.
结论:
- 酸诱导的双细胞衰减可能会因不良粘附而恶化.
- 准确的药物历史和监测对于管理氨酸复杂症至关重要.
- 多学科参与有助于优化治疗和患者的治疗结果.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
616
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
616
Vitamins
2.3K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Mania and Antimanic Drugs: Overview
536
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
536
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
802
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
802


